Irina M. Fedorova
Research Subjects
Research Interests
Irina M. Fedorova has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
- Svetlana I. Koteleva
G.N. Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology
17 shared publications - Mariya S. Blyakher
G.N. Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology
13 shared publications - Ivan V. Kapustin
G.N. Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology
10 shared publications - Olga P. Popova
Russian Medical Academy of Continuous Professional Education
9 shared publications - Evgeny E. Odintsov
G.N. Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology
5 shared publications - Svetlana V. Sandalova
G.N. Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology
5 shared publications
Latest Publications
- 18 May 2026
- Published by Federal Scientific Center for Hygiene F.F.Erisman in Hygiene and sanitation
- Vol. 105 (4)
Influence of the in vitro effect of electromagnetic radiation from a mobile phone on the antigen-specific activity of blood T-lymphocytes in people who have had COVID-19
Introduction. The immune system is one of the objects most sensitive to the effects of the electromagnetic fields. At the same time, the opinion that the effect of radio frequency EMR on cells, tissues, and systems of living organisms is shown at the present stage as distinct and significant is not generally accepted.The aim of the work was to study the effect of EMR on the activity of immune memory T cells against the SARS-CoV-2 virus in vitro when using an irradiation regime corresponding to the usual use of a mobile phone.Materials and methods. The test equipment is a mobile phone with parameters: SAR for the body 1.18 W/kg, for the head 1.25 W/kg, the maximum possible number of functions (bluetooth, WiFi) are connected to the phone.The object of the research was blood samples from forty six people who had suffered from COVID-19 (22 people were ill from November 2020 to July 2021 and 24 were ill from December 2022 to March 2023).Polystyrene plates from the SARS-CoV-2-IgG-ELISA test systems were used for antigenic stimulation (produced by JSC Vector-Best, Russia). To assess the effect of mobile phone EMR, each cell sample (intact or AG-stimulated) was divided into 2 portions. One portion was incubated for 4 hours in the presence of an EMP mobile phone, the second without it. Next, the concentration of interferon-gamma (IFN-γ) in the filler fluid was determined by the ELISA method on test systems from the same company.Results. The effect of EMR has been shown to be expressed in a significant (p < 0.05) decrease in the activity of memory T cells, which, after exposure to EMR, produce IFN-γ weaker during antigen recognition. Only in 4 out of 46 patients, increased activity of memory T cells was detected during antigenic stimulation of lymphocytes in the presence of mobile phone EMR. The average decrease in IFN-γ production was 151.3 ± 80.8 pg/ml or 66.6 ± 11.4% of the baseline level of antigen-stimulated IFN-γ production by patient lymphocytes.Limitations: the use of an in vitro approach.Conclusion. Further investigation of the effect of electromagnetic radiation from a mobile phone on AG-induced lymphocyte activity in people who have suffered from COVID-19 will determine whether the hypersensitivity of AG-specific cells to EMR is associated with impaired immune regulation due to the disease, or EMR can adversly affect AG-specific T cells in healthy people.Compliance with ethical standards. All T-donors gave informed consent to participate in the study, approved by the Ethics Committee of the G.N. Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology (Protocol No. 41 dated 12/10/2020).Contribution: Kapustin I.V. – analysis of experimental data, design of illustrations; Tulskaya E.A. – literature data analysis, database maintenance; Blyakher M.S. – research concept and design, editing; Sandalova S.V. – literature data analysis, material collection; Odintsov E.E. – material collection, editing; Koteleva S.I. – cultural research, text writing; Ramazanova Z.K. – collection of material; Fedorova I.M. – statistical processing, text writing. All authors are responsible for the integrity of all parts of the manuscript and approval of the manuscript final version.Conflict of interest. The authors declare no conflict of interest.Funding. The study had no sponsorship.Received: April 2, 2025 / Revised: November 24, 2025 / Accepted: March 24, 2026 / Published: May 18, 2026
- 18 May 2026
- Published by Federal Scientific Center for Hygiene F.F.Erisman in Hygiene and sanitation
- Vol. 105 (4)
Influence of the in vitro effect of electromagnetic radiation from a mobile phone on the antigen-specific activity of blood T-lymphocytes in people who have had COVID-19
Introduction. The immune system is one of the objects most sensitive to the effects of the electromagnetic fields. At the same time, the opinion that the effect of radio frequency EMR on cells, tissues, and systems of living organisms is shown at the present stage as distinct and significant is not generally accepted.The aim of the work was to study the effect of EMR on the activity of immune memory T cells against the SARS-CoV-2 virus in vitro when using an irradiation regime corresponding to the usual use of a mobile phone.Materials and methods. The test equipment is a mobile phone with parameters: SAR for the body 1.18 W/kg, for the head 1.25 W/kg, the maximum possible number of functions (bluetooth, WiFi) are connected to the phone.The object of the research was blood samples from forty six people who had suffered from COVID-19 (22 people were ill from November 2020 to July 2021 and 24 were ill from December 2022 to March 2023).Polystyrene plates from the SARS-CoV-2-IgG-ELISA test systems were used for antigenic stimulation (produced by JSC Vector-Best, Russia). To assess the effect of mobile phone EMR, each cell sample (intact or AG-stimulated) was divided into 2 portions. One portion was incubated for 4 hours in the presence of an EMP mobile phone, the second without it. Next, the concentration of interferon-gamma (IFN-γ) in the filler fluid was determined by the ELISA method on test systems from the same company.Results. The effect of EMR has been shown to be expressed in a significant (p < 0.05) decrease in the activity of memory T cells, which, after exposure to EMR, produce IFN-γ weaker during antigen recognition. Only in 4 out of 46 patients, increased activity of memory T cells was detected during antigenic stimulation of lymphocytes in the presence of mobile phone EMR. The average decrease in IFN-γ production was 151.3 ± 80.8 pg/ml or 66.6 ± 11.4% of the baseline level of antigen-stimulated IFN-γ production by patient lymphocytes.Limitations: the use of an in vitro approach.Conclusion. Further investigation of the effect of electromagnetic radiation from a mobile phone on AG-induced lymphocyte activity in people who have suffered from COVID-19 will determine whether the hypersensitivity of AG-specific cells to EMR is associated with impaired immune regulation due to the disease, or EMR can adversly affect AG-specific T cells in healthy people.Compliance with ethical standards. All T-donors gave informed consent to participate in the study, approved by the Ethics Committee of the G.N. Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology (Protocol No. 41 dated 12/10/2020).Contribution: Kapustin I.V. – analysis of experimental data, design of illustrations; Tulskaya E.A. – literature data analysis, database maintenance; Blyakher M.S. – research concept and design, editing; Sandalova S.V. – literature data analysis, material collection; Odintsov E.E. – material collection, editing; Koteleva S.I. – cultural research, text writing; Ramazanova Z.K. – collection of material; Fedorova I.M. – statistical processing, text writing. All authors are responsible for the integrity of all parts of the manuscript and approval of the manuscript final version.Conflict of interest. The authors declare no conflict of interest.Funding. The study had no sponsorship.Received: April 2, 2025 / Revised: November 24, 2025 / Accepted: March 24, 2026 / Published: May 18, 2026
- 14 May 2025
- Published by The National Academy of Pediatric Science and Innovation in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
- Vol. 70 (2) , 45-51
Humoral and T-cell immune response against SARS-CoV-2 in children with acute respiratory infections
Objective. The aim was to evaluate specific T-cell and antibodies against SARS-CoV-2 in children hospitalized with respiratory infectious diseases.Materials and methods. Examination of 121 children was carried out in 2021–2024. Among them 22% of patients were under 1 year of age, 33% — 1–3 years, 21% 4–6 years, 24% 7–14 years. In 51 children acute respiratory infection was concomitant with the course of pertussis. Diagnosis of acute respiratory viral infections was based on clinical data and on PCR testing of nasopharyngeal mucus including PCR testing for SARS-CoV-2. Using a method we developed, memory T cells specific to the SARS-CoV-2 S-glycoprotein were assessed in patients' blood. IgG- and IgM-antibodies to SARS-CoV-2 S-glycoprotein in blood serum were also tested.Results. IgG antibodies to S-glycoprotein SARS-CoV-2 were detected in the blood of 55% of children in 2021, 65% in 2022, 82% in 2023, and 96% in 2024. T lymphocytes activated by stimulation with recombinant S-glycoprotein SARS-CoV-2 were detected in the blood of 25% of children in 2021, 70% in 2022 and 19–35% in 2023–2024. A significant (55%) frequency of serologic markers of transmitted undiagnosed COVID-19 was found in children under 3 years of age whose contacts, especially in 2021, were limited to family. In the groups of patients 3–14 years old, even more children were seropositive (95–100%). Memory T cells were found less frequently in children younger 3 years than after 3 years of age.Conclusion. Examination of individuals with various respiratory diseases can clarify ideas about what part of the population has acquired immunity against SARS-CoV-2, as well as assess the role of memory T cells and antibodies to “ancestral” and current strains of SARS-CoV-2 in limiting morbidity.
- 14 May 2025
- Published by The National Academy of Pediatric Science and Innovation in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
- Vol. 70 (2) , 45-51
Humoral and T-cell immune response against SARS-CoV-2 in children with acute respiratory infections
Objective. The aim was to evaluate specific T-cell and antibodies against SARS-CoV-2 in children hospitalized with respiratory infectious diseases.Materials and methods. Examination of 121 children was carried out in 2021–2024. Among them 22% of patients were under 1 year of age, 33% — 1–3 years, 21% 4–6 years, 24% 7–14 years. In 51 children acute respiratory infection was concomitant with the course of pertussis. Diagnosis of acute respiratory viral infections was based on clinical data and on PCR testing of nasopharyngeal mucus including PCR testing for SARS-CoV-2. Using a method we developed, memory T cells specific to the SARS-CoV-2 S-glycoprotein were assessed in patients' blood. IgG- and IgM-antibodies to SARS-CoV-2 S-glycoprotein in blood serum were also tested.Results. IgG antibodies to S-glycoprotein SARS-CoV-2 were detected in the blood of 55% of children in 2021, 65% in 2022, 82% in 2023, and 96% in 2024. T lymphocytes activated by stimulation with recombinant S-glycoprotein SARS-CoV-2 were detected in the blood of 25% of children in 2021, 70% in 2022 and 19–35% in 2023–2024. A significant (55%) frequency of serologic markers of transmitted undiagnosed COVID-19 was found in children under 3 years of age whose contacts, especially in 2021, were limited to family. In the groups of patients 3–14 years old, even more children were seropositive (95–100%). Memory T cells were found less frequently in children younger 3 years than after 3 years of age.Conclusion. Examination of individuals with various respiratory diseases can clarify ideas about what part of the population has acquired immunity against SARS-CoV-2, as well as assess the role of memory T cells and antibodies to “ancestral” and current strains of SARS-CoV-2 in limiting morbidity.
- 1 January 2025
- Published by Dynasty Publishing House in Voprosy praktičeskoj pediatrii
- Vol. 20 (3)
Features of whooping cough in adolescents: clinical, diagnostic, and immunological aspects
Objective. To analyze the clinical, diagnostic, and immunological characteristics of pertussis in adolescents. Patients and methods. The analysis is based on observations of 90 adolescents hospitalized in 2023–2024 with a diagnosis of pertussis. In 64 (71.1%) children, pertussis was observed in combination with other respiratory diseases. To verify the primary diagnosis, polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA) methods were used; to diagnose acute respiratory viral infection, PCR was used, and for mycoplasma infection, the ELISA method was used. Immunological studies included assessment of lymphocyte subpopulation composition, interferon system, serum IgE content, and spectrum of antibodies against Bordetella pertussis. Results. Whooping cough in adolescents was characterized by a typical clinical symptom complex, but it was noteworthy that patients were admitted to the hospital mainly in the late stages of the disease: 60.4% of patients were hospitalized in the 5th week, 39.6% in the 4th week of the disease. At the same time, 83 (92.2%) patients had a moderate form of the disease, 5 (5.6%) had a severe form, and 2 (2.2%) had a mild form. The most characteristic immune status abnormalities were low NK cell (CD3–CD16+CD56+) counts, detected in 53.7% of patients. The CD4/CD8 ratio was below reference values in 58.5% of adolescents. Changes in the interferon system mainly affected the ability of lymphocytes to produce interferon-γ: low values were detected in 63.4% of patients. Conclusion. The analysis demonstrates that pertussis in adolescents typically manifests as moderate forms of the disease, with severe forms being recorded in recent years. Noteworthy are the prolonged prodromal period, the pronounced psychoemotional component of the whooping cough symptom complex, and the high frequency of mixed infections. Immunological studies have revealed changes in the cellular link and interferon system, as well as an increase in serum IgE in a significant number of patients. Key words: whooping cough, cough, adolescents, acute respiratry viral infections, lymphocyte subpopulations, interferon protection
- 1 January 2025
- Published by Dynasty Publishing House in Voprosy praktičeskoj pediatrii
- Vol. 20 (3)
Features of whooping cough in adolescents: clinical, diagnostic, and immunological aspects
Objective. To analyze the clinical, diagnostic, and immunological characteristics of pertussis in adolescents. Patients and methods. The analysis is based on observations of 90 adolescents hospitalized in 2023–2024 with a diagnosis of pertussis. In 64 (71.1%) children, pertussis was observed in combination with other respiratory diseases. To verify the primary diagnosis, polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA) methods were used; to diagnose acute respiratory viral infection, PCR was used, and for mycoplasma infection, the ELISA method was used. Immunological studies included assessment of lymphocyte subpopulation composition, interferon system, serum IgE content, and spectrum of antibodies against Bordetella pertussis. Results. Whooping cough in adolescents was characterized by a typical clinical symptom complex, but it was noteworthy that patients were admitted to the hospital mainly in the late stages of the disease: 60.4% of patients were hospitalized in the 5th week, 39.6% in the 4th week of the disease. At the same time, 83 (92.2%) patients had a moderate form of the disease, 5 (5.6%) had a severe form, and 2 (2.2%) had a mild form. The most characteristic immune status abnormalities were low NK cell (CD3–CD16+CD56+) counts, detected in 53.7% of patients. The CD4/CD8 ratio was below reference values in 58.5% of adolescents. Changes in the interferon system mainly affected the ability of lymphocytes to produce interferon-γ: low values were detected in 63.4% of patients. Conclusion. The analysis demonstrates that pertussis in adolescents typically manifests as moderate forms of the disease, with severe forms being recorded in recent years. Noteworthy are the prolonged prodromal period, the pronounced psychoemotional component of the whooping cough symptom complex, and the high frequency of mixed infections. Immunological studies have revealed changes in the cellular link and interferon system, as well as an increase in serum IgE in a significant number of patients. Key words: whooping cough, cough, adolescents, acute respiratry viral infections, lymphocyte subpopulations, interferon protection
- Open Access
- 16 November 2024
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 23 (4) , 54-56
Familial focus of combined course of whooping cough and measles: clinical observation
The incidence of whooping cough is usually higher than the official statistics due to underdiagnosis of the infection, especially in older children. The significant increase in the incidence of measles and whooping cough in recent years has been reflected in the modern problem of mixed infections. We had the opportunity to observe patients with whooping cough combined with measles in a family outbreak in two unvaccinated sisters aged 10 and 13.
- 16 November 2024
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 23 (4) , 54-56
Open AccessFamilial focus of combined course of whooping cough and measles: clinical observation
The incidence of whooping cough is usually higher than the official statistics due to underdiagnosis of the infection, especially in older children. The significant increase in the incidence of measles and whooping cough in recent years has been reflected in the modern problem of mixed infections. We had the opportunity to observe patients with whooping cough combined with measles in a family outbreak in two unvaccinated sisters aged 10 and 13.
- Open Access
- 22 March 2024
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 23 (1) , 12-17
Metapneumovirus infection in children in modern conditions: clinical and immunological parallels
Aim. The study of metapneumovirus infection clinical and immunological features in children of different ages. Patients and methods. An analysis of 22 patients with mono-metapneumovirus infection is presented. There were 7 (31.8%) children under the age of 1 year, 8 (36.4%) — 1—3 years old, 7 (31.8%) — 4—7 years old. Diagnosis of metapneumovirus infection was based on clinical data and on PCR analysis of nasopharyngeal mucus. Immunological studies in 10 patients included immunophenotype of patient's blood lymphocytes and analysis of the interferon system. Results. Among children under the age of 1 year 71.4 ± 17.1% were diagnosed with obstructive bronchitis and 28.6 ± 17.1% had pneumonia. In patients aged 1—3 years pneumonia was observed more often (55.6 ± 17.6%), obstructive bronchitis — less often (33.3 ± 16.7%), and in 11.1 ± 11.1% bronchitis occurred without symptoms of bronchial obstruction. In children aged 4—7 years only the upper respiratory tract was affected in 14.3 ± 13.2% of cases, 57.1 ± 18.7% developed bronchitis and 28.6 ± 17.1% — pneumonia. The immune system state was characterized by a low content of T-helpers (CD3 + CD4 + ) and NK-cells (CD3-CD16 + CD56 + ) detected in 7 (70%) and 5 (50%) patients respectively. IFNγ production was reduced in 70% of children and IFNα in 80%. Conclusion. Metapneumovirus infection in children in modern conditions is characterized by the frequent development of inflammatory changes in the bronchopulmonary system in the early stages of the disease. The disease severity was due to both manifestations of respiratory failure and severe symptoms of intoxication. Immunological studies revealed changes in the cellular link and the interferon system in all age groups.
- 22 March 2024
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 23 (1) , 12-17
Open AccessMetapneumovirus infection in children in modern conditions: clinical and immunological parallels
Aim. The study of metapneumovirus infection clinical and immunological features in children of different ages. Patients and methods. An analysis of 22 patients with mono-metapneumovirus infection is presented. There were 7 (31.8%) children under the age of 1 year, 8 (36.4%) — 1—3 years old, 7 (31.8%) — 4—7 years old. Diagnosis of metapneumovirus infection was based on clinical data and on PCR analysis of nasopharyngeal mucus. Immunological studies in 10 patients included immunophenotype of patient's blood lymphocytes and analysis of the interferon system. Results. Among children under the age of 1 year 71.4 ± 17.1% were diagnosed with obstructive bronchitis and 28.6 ± 17.1% had pneumonia. In patients aged 1—3 years pneumonia was observed more often (55.6 ± 17.6%), obstructive bronchitis — less often (33.3 ± 16.7%), and in 11.1 ± 11.1% bronchitis occurred without symptoms of bronchial obstruction. In children aged 4—7 years only the upper respiratory tract was affected in 14.3 ± 13.2% of cases, 57.1 ± 18.7% developed bronchitis and 28.6 ± 17.1% — pneumonia. The immune system state was characterized by a low content of T-helpers (CD3 + CD4 + ) and NK-cells (CD3-CD16 + CD56 + ) detected in 7 (70%) and 5 (50%) patients respectively. IFNγ production was reduced in 70% of children and IFNα in 80%. Conclusion. Metapneumovirus infection in children in modern conditions is characterized by the frequent development of inflammatory changes in the bronchopulmonary system in the early stages of the disease. The disease severity was due to both manifestations of respiratory failure and severe symptoms of intoxication. Immunological studies revealed changes in the cellular link and the interferon system in all age groups.
- 1 January 2024
- Published by Dynasty Publishing House in Infekcionnye bolezni
- Vol. 22 (1)
Whooping cough in young children: risks of adverse course and modern approaches to prevention
Objective. To analyze the features of whooping cough in patients under 1 year of age and the state of transplacental protection in children under 1 month of age in modern conditions. Patients and methods. The clinical analysis of whooping cough features in children under 1 year of age is based on observations of 424 patients hospitalized in the Clinical Hospital of Infectious Diseases No 1 in the period of 2017–2019. To verify whooping cough, PCR and ELISA methods were used with the Ridascreen/Bordetella pertussis test system (R-biofarm AMG, Germany), which allows detecting antibodies of various classes (IgM, IgG, IgA). Serological screening to detect antibodies to pertussis antigens was carried out in 52 children under the age of 1 month, hospitalized in various hospitals for newborns in Moscow. Results. Analysis of clinical forms showed that among hospitalized patients, severe forms were observed much more often among children aged 1–3 months, accounting for 38.0 ± 3.8% (63 children) versus 7.0 ± 2.4% (8 children) aged 4–6 months (p < 0.001) and 5.6 ± 1.9% (8 children) aged 7–12 months (p < 0.001). In all age groups, moderate severity of the disease prevailed, occurring in 59.6 ± 3.8%, 86.8 ± 3.2%, and 90.3 ± 2.5% of children, respectively. Analysis of antibodies transplacental transfer in newborns showed that IgG antibodies were detected below the threshold level in 37 (71.1 ± 6.3%) blood serum samples, 3 (5.8 ± 3.2%) corresponded to the threshold values, and 12 (23.3 ± 5.8%) were above the threshold. The predominance of seronegative children proportion suggests a possible high risk of the disease in children of this age with severe forms of whooping cough. Conclusion. Given the severe course and the presence of fatal outcomes in children of the first months of life, it is advisable to vaccinate pregnant women to create passive immunity in newborns. Key words: whooping cough, clinical forms, antibodies, newborns, passive immunity
- 1 January 2024
- Published by Dynasty Publishing House in Infekcionnye bolezni
- Vol. 22 (1)
Whooping cough in young children: risks of adverse course and modern approaches to prevention
Objective. To analyze the features of whooping cough in patients under 1 year of age and the state of transplacental protection in children under 1 month of age in modern conditions. Patients and methods. The clinical analysis of whooping cough features in children under 1 year of age is based on observations of 424 patients hospitalized in the Clinical Hospital of Infectious Diseases No 1 in the period of 2017–2019. To verify whooping cough, PCR and ELISA methods were used with the Ridascreen/Bordetella pertussis test system (R-biofarm AMG, Germany), which allows detecting antibodies of various classes (IgM, IgG, IgA). Serological screening to detect antibodies to pertussis antigens was carried out in 52 children under the age of 1 month, hospitalized in various hospitals for newborns in Moscow. Results. Analysis of clinical forms showed that among hospitalized patients, severe forms were observed much more often among children aged 1–3 months, accounting for 38.0 ± 3.8% (63 children) versus 7.0 ± 2.4% (8 children) aged 4–6 months (p < 0.001) and 5.6 ± 1.9% (8 children) aged 7–12 months (p < 0.001). In all age groups, moderate severity of the disease prevailed, occurring in 59.6 ± 3.8%, 86.8 ± 3.2%, and 90.3 ± 2.5% of children, respectively. Analysis of antibodies transplacental transfer in newborns showed that IgG antibodies were detected below the threshold level in 37 (71.1 ± 6.3%) blood serum samples, 3 (5.8 ± 3.2%) corresponded to the threshold values, and 12 (23.3 ± 5.8%) were above the threshold. The predominance of seronegative children proportion suggests a possible high risk of the disease in children of this age with severe forms of whooping cough. Conclusion. Given the severe course and the presence of fatal outcomes in children of the first months of life, it is advisable to vaccinate pregnant women to create passive immunity in newborns. Key words: whooping cough, clinical forms, antibodies, newborns, passive immunity
- Open Access
- 17 November 2023
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 22 (4) , 43-47
Experience of using inhaled steroid therapy in children with whooping cough
The aim of study: аnalysis of the effectiveness of inhaled steroid therapy in patients with whooping cough.Materials and methods: 74 patients with whooping cough were observed, among whom 40 children included inhalations with Budesonide in complex therapy (main group). 34 patients in the comparison group received only basic therapy. The age structure in the main group was as follow: тhere were children under one years old 18 (47.4 ± 8.1%), 1—3 years — 7 (18.4 ± 6.3%); 4—6 years — 8 (21 ± 6.6%), 7—14 years — 7 (13.2 ± 5.5%) and comparable to the comparison group. To verify whooping cough were used the PCR method and serological diagnostic (IFA) using a test system “Ridascreen/Bordetella pertussis («R-biofarm AMG», Germany). Results: budеsonide was prescribed for a course of 5—7 days. Clinical analysis of dynamics of cough in main group showed, that a reduction in a number of attacks by the 4—5th day of budesonide was observed in majority of children (35/87.5 ± 5.2%). In the main group coughing attacks with a frequency of more than 15—25 times a day persisted for 2.7 ± 0.2 days, and in comparison group — 4.3 ± 0.2 (p < 0.001). Relief of broncho-obstructive syndrome was observed in shorter period of time, which contributes to a reduction in the average length of stay of the patient in the hospital.
- 17 November 2023
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 22 (4) , 43-47
Open AccessExperience of using inhaled steroid therapy in children with whooping cough
The aim of study: аnalysis of the effectiveness of inhaled steroid therapy in patients with whooping cough.Materials and methods: 74 patients with whooping cough were observed, among whom 40 children included inhalations with Budesonide in complex therapy (main group). 34 patients in the comparison group received only basic therapy. The age structure in the main group was as follow: тhere were children under one years old 18 (47.4 ± 8.1%), 1—3 years — 7 (18.4 ± 6.3%); 4—6 years — 8 (21 ± 6.6%), 7—14 years — 7 (13.2 ± 5.5%) and comparable to the comparison group. To verify whooping cough were used the PCR method and serological diagnostic (IFA) using a test system “Ridascreen/Bordetella pertussis («R-biofarm AMG», Germany). Results: budеsonide was prescribed for a course of 5—7 days. Clinical analysis of dynamics of cough in main group showed, that a reduction in a number of attacks by the 4—5th day of budesonide was observed in majority of children (35/87.5 ± 5.2%). In the main group coughing attacks with a frequency of more than 15—25 times a day persisted for 2.7 ± 0.2 days, and in comparison group — 4.3 ± 0.2 (p < 0.001). Relief of broncho-obstructive syndrome was observed in shorter period of time, which contributes to a reduction in the average length of stay of the patient in the hospital.
- Open Access
- 6 July 2023
- Published by Central Research Institute for Epidemiology in Problems of Virology
- Vol. 68 (3) , 205-214
Development and preservation of specific T-cell immunity after COVID-19 or vaccination against this infection
Aim evaluation of specific T-cell immunity against SARS-CoV-2 in primary and secondary response to virus antigens by screening method. Materials and methods. Patients were tested 11.5 months after COVID-19 and 610 months before and after vaccination. Healthy volunteers were screened before, 26 times during the vaccination course, and 68 months after revaccination with the Sputnik V vaccine. IgG and IgM antibodies to SARS-CoV-2 were detected by ELISA using commercially available kits (Vector-Best, Russia). Antigenic (AG) activation of T cells in the fraction of bloods mononuclear cells was assessed by IFN- production after AG stimulation in the wells of plates from ELISA kits intended for detection of antibodies against SARS-CoV-2. Data were processed by MS Excel and Statistica 10.0 software. Results. AG-specific T cells were detected in 88.5% of vaccinated healthy volunteers, half of whom were found to have T cells appearing earlier than antibodies to AG. After 6-8 months, the level of AG activation decreases. Following the revaccination, the level of AG activation of memory T cells in vitro increases within six months in 76.9100.0% of vaccinated subjects. On the contrary, after COVID-19, 86.7% of individuals had in their blood the AG-specific T cells with high activity at the time of vaccination. The activity of T cells recognizing the RBD domain of the SARS-CoV-2 S protein and the proportion of individuals who had these cells in their blood increased after the vaccination of reconvalescents. Conclusion. T-cell immunity against SARS-CoV-2 antigens has been shown to persist for 6 months after illness. In vaccinated individuals without history of COVID-19, such duration of the preservation of AG-specific T cells in blood was only achieved after the revaccination.
- 6 July 2023
- Published by Central Research Institute for Epidemiology in Problems of Virology
- Vol. 68 (3) , 205-214
Open AccessDevelopment and preservation of specific T-cell immunity after COVID-19 or vaccination against this infection
Aim evaluation of specific T-cell immunity against SARS-CoV-2 in primary and secondary response to virus antigens by screening method. Materials and methods. Patients were tested 11.5 months after COVID-19 and 610 months before and after vaccination. Healthy volunteers were screened before, 26 times during the vaccination course, and 68 months after revaccination with the Sputnik V vaccine. IgG and IgM antibodies to SARS-CoV-2 were detected by ELISA using commercially available kits (Vector-Best, Russia). Antigenic (AG) activation of T cells in the fraction of bloods mononuclear cells was assessed by IFN- production after AG stimulation in the wells of plates from ELISA kits intended for detection of antibodies against SARS-CoV-2. Data were processed by MS Excel and Statistica 10.0 software. Results. AG-specific T cells were detected in 88.5% of vaccinated healthy volunteers, half of whom were found to have T cells appearing earlier than antibodies to AG. After 6-8 months, the level of AG activation decreases. Following the revaccination, the level of AG activation of memory T cells in vitro increases within six months in 76.9100.0% of vaccinated subjects. On the contrary, after COVID-19, 86.7% of individuals had in their blood the AG-specific T cells with high activity at the time of vaccination. The activity of T cells recognizing the RBD domain of the SARS-CoV-2 S protein and the proportion of individuals who had these cells in their blood increased after the vaccination of reconvalescents. Conclusion. T-cell immunity against SARS-CoV-2 antigens has been shown to persist for 6 months after illness. In vaccinated individuals without history of COVID-19, such duration of the preservation of AG-specific T cells in blood was only achieved after the revaccination.
- Open Access
- 7 December 2022
- Published by Central Research Institute for Epidemiology in Problems of Virology
- Vol. 67 (6) , 527-537
Assesment of specific T-cell immunity to SARS-CoV-2 virus antigens in COVID-19 reconvalescents
Introduction. The development of the COVID-19 pandemic has stimulated the scientific research aimed at studying of the mechanisms of formation the immunity against SARS-CoV-2. Currently, there is a need to develop a domestic simple and cost-effective specific method suitable for monitoring of T-cell response against SARS-CoV-2 in reconvalescents and vaccinated individuals. Aim: Development of a screening method for evaluation specific T-cell immunity against SARS-CoV-2. Materials and methods. Total 40 individuals who had mild to moderate COVID-19 and 20 healthy volunteers who did not have a history of this disease were examined. The presence and levels of IgG and IgM antibodies to SARS-CoV-2 were identified in participants sera by ELISA using the diagnostic kits from JSC Vector-Best (Novosibirsk, Russian Federation). Antigenic stimulation of mononuclear cells was carried out on commercial plates with adsorbed whole-virion inactivated SARS-CoV-2 antigen (State Research Center of Virology and Biotechnology VECTOR Novosibirsk, Russian Federation). The concentration of IFN- was measured in ELISA using the test systems from JSC Vector-Best (Novosibirsk, Russian Federation). The immunophenotyping of lymphocytes was performed on a flow cytometer Cytomics FC500 (Beckman Coulter, USA). Statistical data processing was carried out using the Microsoft Excel and STATISTICA 10 software package. Results. Stimulation of mononuclear cells isolated from the peripheral blood with whole-virion inactivated SARS-CoV-2 antigen fixed at the bottom of the wells of a polystyrene plate showed a significantly higher median response in terms of IFN- production in 40 people who had history of COVID-19 compared to 20 healthy blood donors (172.1 [34.3575.1] pg/ml versus 15.4 [6.925.8] pg/ml, p 0.0001). There was no difference in median IFN- levels in supernatants collected from unstimulated mononuclear cells from COVID-19 reconvalescents and healthy donors (2.7 [0.411.4] pg/ml versus 0.8 [0.023.3] pg/ml, p 0.05). The overall sensitivity and specificity of this method were 73% (95% CI 5888%) and 100% (95% CI 100100%), respectively, at a cut-off of 50 pg/ml. Conclusion. The developed method for assessment of the cellular immune response to SARS-CoV-2 can be used as a screening method for monitoring the T-cell response in a population against a new coronavirus infection in recovered people.
- 7 December 2022
- Published by Central Research Institute for Epidemiology in Problems of Virology
- Vol. 67 (6) , 527-537
Open AccessAssesment of specific T-cell immunity to SARS-CoV-2 virus antigens in COVID-19 reconvalescents
Introduction. The development of the COVID-19 pandemic has stimulated the scientific research aimed at studying of the mechanisms of formation the immunity against SARS-CoV-2. Currently, there is a need to develop a domestic simple and cost-effective specific method suitable for monitoring of T-cell response against SARS-CoV-2 in reconvalescents and vaccinated individuals. Aim: Development of a screening method for evaluation specific T-cell immunity against SARS-CoV-2. Materials and methods. Total 40 individuals who had mild to moderate COVID-19 and 20 healthy volunteers who did not have a history of this disease were examined. The presence and levels of IgG and IgM antibodies to SARS-CoV-2 were identified in participants sera by ELISA using the diagnostic kits from JSC Vector-Best (Novosibirsk, Russian Federation). Antigenic stimulation of mononuclear cells was carried out on commercial plates with adsorbed whole-virion inactivated SARS-CoV-2 antigen (State Research Center of Virology and Biotechnology VECTOR Novosibirsk, Russian Federation). The concentration of IFN- was measured in ELISA using the test systems from JSC Vector-Best (Novosibirsk, Russian Federation). The immunophenotyping of lymphocytes was performed on a flow cytometer Cytomics FC500 (Beckman Coulter, USA). Statistical data processing was carried out using the Microsoft Excel and STATISTICA 10 software package. Results. Stimulation of mononuclear cells isolated from the peripheral blood with whole-virion inactivated SARS-CoV-2 antigen fixed at the bottom of the wells of a polystyrene plate showed a significantly higher median response in terms of IFN- production in 40 people who had history of COVID-19 compared to 20 healthy blood donors (172.1 [34.3575.1] pg/ml versus 15.4 [6.925.8] pg/ml, p 0.0001). There was no difference in median IFN- levels in supernatants collected from unstimulated mononuclear cells from COVID-19 reconvalescents and healthy donors (2.7 [0.411.4] pg/ml versus 0.8 [0.023.3] pg/ml, p 0.05). The overall sensitivity and specificity of this method were 73% (95% CI 5888%) and 100% (95% CI 100100%), respectively, at a cut-off of 50 pg/ml. Conclusion. The developed method for assessment of the cellular immune response to SARS-CoV-2 can be used as a screening method for monitoring the T-cell response in a population against a new coronavirus infection in recovered people.